跳至主要内容
临床试验/ACTRN12617000395336
ACTRN12617000395336已完成4 期

Targeting neutrophil extracellular traps with dornase alfa to reduce inflammation in chronic airway disease

niversity of Newcastle0 个研究点目标入组 30 人开始时间: 2017年3月17日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Males and females aged >18 years with Doctor diagnosed stable COPD, confirmed by incompletely reversible airflow obstruction (post bronchodilator FEV1<80% predicted and FEV1/FVC<70%)
  • Males and females aged >18 years with Doctor diagnosed stable asthma
  • Non-smokers or ex-smokers (> 6 months since last cigarette).
  • High levels of sputum NETs (>20ng/uL eDNA, conducted in Aim 1) (determined after screening visit)

排除标准

  • COPD or asthma exacerbation or respiratory tract infection (OCS or antibiotics), or change in maintenance therapy in the past 6 weeks (visit will be postponed)
  • Current smoking (last 6 months)
  • Any use of antibiotics in the past month (visit will be postponed)
  • Pregnancy or breastfeeding
  • Inability to attend clinic visits
  • Other significant illness likely to interfere with management or participation in the study
  • Participation in any other interventional research study in the last 4 weeks

研究者

发起方
niversity of Newcastle

相似试验